RT Journal Article
SR Electronic
T1 A Platform for Data-centric, Continuous Epidemiological Analyses
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.19.22274026
DO 10.1101/2022.04.19.22274026
A1 Flávio Codeço Coelho
A1 Daniel Câmara
A1 Eduardo Araújo
A1 Lucas Bianchi
A1 Ivan Ogasawara
A1 Jyoti Dalal
A1 Ananthu James
A1 Jessica Lee Abbate
A1 Aziza Merzouki
A1 Izabel Reis
A1 Kenechukwu Nwosu
A1 Olivia Keiser
YR 2022
UL http://medrxiv.org/content/early/2022/04/22/2022.04.19.22274026.abstract
AB Guaranteeing durability, provenance, accessibility, and trust in open datasets can be challenging for researchers and organizations that rely on public repositories of data critical to epidemiology and other health analytics. Not only are the required repositories sometimes difficult to locate, and nearly always require conversion into a compatible format, they may move or change unpredictably. Any single change of the rules in one repository can hinder updating of a public dashboard reliant on pulling data from external sources. These concerns are particularly challenging at the international level, because systems aimed at harmonizing health and related data are typically dictated by national governments to serve their individual needs. In this paper, we introduce a comprehensive public health data platform, the EpiGraphHub, that aims to provide a single interoperable repository for open health and related data, curated by the international research community, which allows secure local integration of sensitive databases whilst facilitating the development of data-driven applications and reports for decision-makers. The platform development is co-funded by the World Health Organization and is fully open-source to maximize its value for large-scale public health studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe World Health Organization and the Swiss National Science FoundationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://epigraphhub.org